National Research Council (US) Committee (2011) Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press, Washington DC
Chen CS, He MY, Zhu YC, Shi L, Wang XD (2015) Five critical elements to ensure the precision medicine. Cancer Metastasis Rev 34(2):311
Article
Google Scholar
Reardon S (2015) Precision-medicine plan raises hopes. Nature 517(7536):540
Article
PubMed
CAS
Google Scholar
Garraway LA, Lander ES (2013) Lessons from the cancer genome. Cell 153(1):17–37
Article
PubMed
CAS
Google Scholar
Collins FS, Varmus H (2015) A new initiative on precision medicine. N Engl J Med 372(9):793–795
Article
PubMed
CAS
Google Scholar
Abecasis GR, Auton A, Brooks LD et al (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491(7422):56–65
Article
PubMed
Google Scholar
Kuehn BM (2012) 1000 genomes project finds substantial genetic variation among populations. JAMA 308(22):2322–2325
Article
PubMed
CAS
Google Scholar
Torjesen I (2013) Genomes of 100,000 people will be sequenced to create an open access research resource. BMJ 347:f6690
Article
PubMed
Google Scholar
ENCODE Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414):57–74
Article
Google Scholar
Paik YK, Jeong SK, Omenn GS et al (2012) The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome. Nat Biotechnol 30(3):221–223
Article
PubMed
CAS
Google Scholar
Tiirikka T, Moilanen JS (2015) Human chromosome Y and haplogroups; introducing YDHS database. Clin Transl Med 4:20
Article
PubMed Central
Google Scholar
Paik YK, Omenn GS, Thongboonkerd V et al (2014) Genome-wide proteomics, Chromosome-Centric Human Proteome Project (C-HPP), part II. J Proteome Res 13(1):1–4
Article
PubMed
CAS
Google Scholar
Kato Y, Nakamura H, Tojo H et al (2015) A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types. Clin Transl Med 4:24
Article
PubMed Central
Google Scholar
Pavlou MP, Diamandis EP (2010) The cancer cell secretome: a good source for discovering biomarkers? J Proteom 73(10):1896–1906
Article
CAS
Google Scholar
Skalnikova H, Motlik J, Gadher SJ et al (2011) Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 11(4):691–708
Article
PubMed
CAS
Google Scholar
Frantzi M, Bhat A, Latosinska A (2014) Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med 3:7
Article
PubMed
PubMed Central
Google Scholar
Melak T, Gakkhar S (2015) Maximum flow approach to prioritize potential drug targets of Mycobacterium tuberculosis H37Rv from protein–protein interaction network. Clin Transl Med 4:19
Article
PubMed Central
Google Scholar
Gill N, Singh S, Aseri TC (2014) Computational disease gene prioritization: an appraisal. J Comput Biol 21(6):456–465
Article
PubMed
CAS
Google Scholar
Mitsudomi T, Morita S, Yatabe Y et al (2010) Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol 11(2):121–128
Article
PubMed
CAS
Google Scholar
Rosell R, Carcereny E, Gervais R et al (2012) Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol 13(3):239–246
Article
PubMed
CAS
Google Scholar
Dolsten M, Søgaard M (2012) Precision medicine: an approach to R&D for delivering superior medicines to patients. Clin Transl Med 1(1):7
Article
PubMed
PubMed Central
Google Scholar
Zeng T, Wang DC, Wang XD, Xu F, Chen L (2014) Prediction of dynamical drug sensitivity and resistance by module network rewiring-analysis based on transcriptional profiling. Drug Resist Update 17(3):64–76
Article
Google Scholar
Yap TA, Popat S (2014) Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer. Pharmgenomics Pers Med 7:285–295
PubMed
CAS
PubMed Central
Google Scholar